The organ protection of astragalus in subjects with metabolic sydrome

The organ protection of gan su astragalus in subjects with metabolic sydrome

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001747

Enrollment

Unknown

Registered

2011-11-29

Start date

2010-11-25

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic sydrome

Interventions

control:no treatment

astragalus:astagalus treatment

normal treament group:Conventional therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. age 18 years or older meet the diagnostic criteria of MS; 2. non-allergic with the astragalus; 3. agree to conduct clinical trials and those who signed the informed consent

Exclusion criteria

Exclusion criteria: 1. patients with resistant hypertension; 2. renal disease requiring dialysis; 3. heart failure NYHA III or IV; 4. complications of diabetes; 5. arteritis; 6. cancer; 7. thyroid disease; 8. unstable coronary heart disease; 9. peripheral vascular disease; 10. acute cerebral vascular disease; 11. pregnancy, planned pregnancy; 11. patients with anti-oxidants; 12. acute infection; 13. other organic dysfuntion, such as the liver, respiratory system, blood system, and other rheumatic diseases.

Design outcomes

Primary

Measure	Time frame
diastolic function;Ultrasound carotid artery intima-media thickness;Quantification of urinary albumin;Ang II;	—

Secondary

Measure	Time frame
common biochemical test;	—

Countries

China

Contacts

Public ContactYu Jing

yujing2304@126.com+86 13893607559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026